International Association for the Study of Lung Cancer shared a post on LinkedIn:
“IASLC 2026 Hot Topic Meeting: Resistance to Immunotherapy – Registration and Abstract submission are now open!
This meeting will bring together experts to examine the growing challenge of resistance to immunotherapy in lung cancer. Through scientific presentations and clinical perspectives, participants will explore the mechanisms behind resistance and the strategies being developed to overcome it.
Key areas of focus include:
- Biological drivers of primary and acquired resistance.
- Tumor-immune interactions and the impact of the tumor microenvironment.
- Promising biomarkers that may help identify resistance earlier.
- Emerging treatment strategies aimed at improving patient outcomes.
Dublin, Ireland
June 26–27
IASLC Full Members receive the deepest registration discounts for this meeting.
Not a member yet? Join IASLC to access the biggest savings and additional member benefits.”
Other OncoDaily articles about International Association for the Study of Lung Cancer.